IOL CHEMICALS & PHARM. | ABBOTT INDIA | IOL CHEMICALS & PHARM./ ABBOTT INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.4 | 48.2 | 27.7% | View Chart |
P/BV | x | 1.5 | 17.6 | 8.7% | View Chart |
Dividend Yield | % | 1.0 | 1.2 | 81.9% |
IOL CHEMICALS & PHARM. ABBOTT INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ABBOTT INDIA Mar-23 |
IOL CHEMICALS & PHARM./ ABBOTT INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 22,482 | 2.4% | |
Low | Rs | 272 | 16,156 | 1.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 2,517.0 | 15.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 446.8 | 5.3% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 479.7 | 6.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 325.00 | 1.2% | |
Avg Dividend yield | % | 1.0 | 1.7 | 58.8% | |
Book value per share (Unadj.) | Rs | 256.8 | 1,480.5 | 17.3% | |
Shares outstanding (eoy) | m | 58.71 | 21.25 | 276.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 7.7 | 14.0% | |
Avg P/E ratio | x | 17.1 | 43.2 | 39.5% | |
P/CF ratio (eoy) | x | 12.8 | 40.3 | 31.8% | |
Price / Book Value ratio | x | 1.6 | 13.0 | 12.1% | |
Dividend payout | % | 16.9 | 72.7 | 23.2% | |
Avg Mkt Cap | Rs m | 23,743 | 410,513 | 5.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 5,636 | 29.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 53,487 | 41.5% | |
Other income | Rs m | 256 | 1,543 | 16.6% | |
Total revenues | Rs m | 22,427 | 55,030 | 40.8% | |
Gross profit | Rs m | 2,257 | 12,055 | 18.7% | |
Depreciation | Rs m | 462 | 700 | 66.0% | |
Interest | Rs m | 165 | 160 | 103.0% | |
Profit before tax | Rs m | 1,887 | 12,738 | 14.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 3,244 | 15.3% | |
Profit after tax | Rs m | 1,391 | 9,494 | 14.7% | |
Gross profit margin | % | 10.2 | 22.5 | 45.2% | |
Effective tax rate | % | 26.2 | 25.5 | 103.1% | |
Net profit margin | % | 6.3 | 17.8 | 35.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 30,251 | 32.0% | |
Current liabilities | Rs m | 5,025 | 12,060 | 41.7% | |
Net working cap to sales | % | 20.9 | 34.0 | 61.6% | |
Current ratio | x | 1.9 | 2.5 | 76.7% | |
Inventory Days | Days | 43 | 87 | 49.8% | |
Debtors Days | Days | 8 | 2 | 384.6% | |
Net fixed assets | Rs m | 11,017 | 15,135 | 72.8% | |
Share capital | Rs m | 587 | 213 | 276.3% | |
"Free" reserves | Rs m | 14,490 | 31,248 | 46.4% | |
Net worth | Rs m | 15,077 | 31,460 | 47.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 45,386 | 45.6% | |
Interest coverage | x | 12.5 | 80.7 | 15.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.2 | 91.0% | |
Return on assets | % | 7.5 | 21.3 | 35.4% | |
Return on equity | % | 9.2 | 30.2 | 30.6% | |
Return on capital | % | 13.6 | 41.0 | 33.2% | |
Exports to sales | % | 26.7 | 0.4 | 6,467.6% | |
Imports to sales | % | 0 | 10.8 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 221 | 2,680.9% | |
Imports (cif) | Rs m | NA | 5,765 | 0.0% | |
Fx inflow | Rs m | 5,930 | 310 | 1,914.2% | |
Fx outflow | Rs m | 6,052 | 5,818 | 104.0% | |
Net fx | Rs m | -122 | -5,508 | 2.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 8,934 | 13.7% | |
From Investments | Rs m | -1,200 | -1,477 | 81.2% | |
From Financial Activity | Rs m | -41 | -6,387 | 0.6% | |
Net Cashflow | Rs m | -18 | 1,070 | -1.7% |
Indian Promoters | % | 48.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 75.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 9.1 | 18.7% | |
FIIs | % | 1.4 | 0.2 | 777.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 25.0 | 207.2% | |
Shareholders | 130,003 | 69,382 | 187.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Abbott India | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.17% | -0.32% | -0.92% |
1-Month | 8.06% | -9.11% | 1.39% |
1-Year | -1.36% | 15.45% | 51.34% |
3-Year CAGR | -11.55% | 20.94% | 14.50% |
5-Year CAGR | 15.45% | 27.20% | 19.09% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Abbott India share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Abbott India the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Abbott India.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Abbott India paid Rs 325.0, and its dividend payout ratio stood at 72.7%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Abbott India.
For a sector overview, read our pharmaceuticals sector report.
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.